drugset / Trial / NCT00347802

Diurnal Curves With Bimatoprost 0.03% Versus Travoprost 0.004%

NCT00347802

Phase 4 Completed Innovative Medical
RandomizedParallel-groupSingle-blind

Summary

To compare the diurnal curves in patients using bimatoprost 0.03% versus travoprost 0.004% for the treatment of glaucoma or ocular hypertension.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Bimatoprost Other / unclassified 0.03 %
Subject Travoprost Other / unclassified 0.004 %

Indications